Baxter Sheds Poorly Performing Blood Products Line For $540 Mil.
This article was originally published in The Gray Sheet
Executive Summary
Baxter will sell its blood collection and processing business to a pair of investment firms for $540 mil., it announced Oct. 3
You may also be interested in...
People In Brief
Northrup leaves Enzi: With Democrats poised to take the lead of the Senate Health, Education, Labor & Pensions (HELP) Committee, outgoing Chairman Michael Enzi's (R-Wyo.) health policy director Stephen Northrup, former executive director of the Medical Device Manufacturers Association, moves to the law firm Arent Fox Dec. 13 as senior government relations director. David Bowen, health policy director to Sen. Edward Kennedy (D-Mass.), likely will take over as majority director of health policy for the HELP committee in January, when Kennedy is expected to become chairman. The HELP committee has primary jurisdiction in the Senate over FDA activities...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.